论文部分内容阅读
对发育性青光眼按治疗经过分为首选手术组（５４例１００眼）和首选药物组（４８例９５眼）二组，术后追踪３年。结果：首选手术组手术成功率７７％，平均眼压２．６７±１．９９ｋＰａ，视力、视野及Ｃ／Ｄ稳定率分别为７１％、６９％、７１％。首选药物组，坚持治疗达３年以上者仅７例１３只眼，这１３只眼的眼压控制率为５３％，视力、视野及Ｃ／Ｄ稳定率分别为４６％、５３％，４６％。药物治疗的其余４１例８２只眼，分别在用药物后半年至一年半时间内，因眼压不能控制，药物顺从性差或药物的副作用等，转行手术治疗。转行手术后眼压控制率与首选手术组无统计学上的差异（Ｐ＞０．０５）。结果表明发育性青光眼首选手术与首选药物治疗相比，在眼压控制，视力、视野及Ｃ／Ｄ稳定方面均优于首选药物治疗组。因药物治疗顺从性差和欠佳，使８６％的病人在药物治疗过程中转为手术治疗
According to the treatment of developmental glaucoma after treatment was divided into the preferred surgery group (54 cases of 100 eyes) and the preferred drug group (48 cases of 95 eyes) two groups, followed up for 3 years. Results: The success rate of surgical operation was 77%, mean intraocular pressure was 2.67 ± 1.99kPa, visual acuity, visual field and C / D stability were 71%, 69% and 71% respectively. The preferred drug group, adhere to the treatment of up to 3 years or more only 7 cases of 13 eyes, the intraocular pressure control rate was 53% in 13 eyes, visual acuity, visual field and C / D stability were 46%, 53%, 46% . The remaining 41 cases of drug treatment in 82 eyes, respectively, within six months to a year and a half after using drugs, due to intraocular pressure can not be controlled, poor drug compliance or drug side effects, switch operation. There was no significant difference between IOP and control group after operation (P> 0.05). The results showed that preferred glaucoma surgery preferred ophthalmic control, visual acuity, visual field and C / D stability were superior to the preferred drug treatment group compared with the preferred drug treatment. Due to poor and poor compliance with drug treatment, 86% of patients switched to surgery during the course of drug treatment